Phase 3 results for vosaroxin/cytarabine in the subset of patients ≥60 years old with refractory/early relapsed acute myeloid leukemia Letter uri icon

Overview

MeSH Major

  • Myelodysplastic Syndromes

publication date

  • November 2018

Research

keywords

  • Letter

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.3324/haematol.2018.191361

PubMed ID

  • 29794146

Additional Document Info

start page

  • e514

end page

  • e518

volume

  • 103

number

  • 11